Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis

被引:53
作者
Barger, Jennifer F. [1 ]
Plas, David R. [1 ]
机构
[1] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA
关键词
FATTY-ACID SYNTHASE; ACTIVATED PROTEIN-KINASE; ATP-CITRATE LYASE; ACETYL-COA CARBOXYLASE; CONGESTIVE-HEART-FAILURE; HYPOXIA-INDUCIBLE FACTOR; TRACT-BINDING PROTEIN; RENAL-CELL CARCINOMA; BREAST-CANCER CELLS; C-MYC;
D O I
10.1677/ERC-10-0106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer biologists' search for new chemotherapy targets is reinvigorating the study of how cancer cell metabolism determines both oncogenic potential and chemotherapeutic responses. Oncogenic metabolic programs support the bioenergetics associated with resistance to programed cell death and provide biosynthetic building blocks for cell growth and mitogenesis. Both signal transduction pathway activation and direct mutations in key metabolic enzymes can activate the metabolic programs that support cancer cell growth. Cancer-associated metabolic programs include glycolysis, glutamine oxidation, and fatty acid metabolism. Recent observations are revealing the regulatory mechanisms that activate cancer-associated metabolism, and the competitive advantages provided to transformed cells by their metabolic programs. In this study, we review recent results illustrating the mechanisms and functional impact of each of these oncogenic metabolic programs in cancer cell growth and survival. Endocrine-Related Cancer (2010) 17 R287-R304
引用
收藏
页码:R287 / R304
页数:18
相关论文
共 129 条
[31]   SREBP transcription factors:: master regulators of lipid homeostasis [J].
Eberlé, D ;
Hegarty, B ;
Bossard, P ;
Ferré, P ;
Foufelle, F .
BIOCHIMIE, 2004, 86 (11) :839-848
[32]   Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death [J].
Egler, Vivian ;
Korur, Serdar ;
Failly, Mike ;
Boulay, Jean-Louis ;
Imber, Roland ;
Lino, Maria M. ;
Merlo, Adrian .
CLINICAL CANCER RESEARCH, 2008, 14 (10) :3132-3140
[33]   C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation [J].
Epstein, ACR ;
Gleadle, JM ;
McNeill, LA ;
Hewitson, KS ;
O'Rourke, J ;
Mole, DR ;
Mukherji, M ;
Metzen, E ;
Wilson, MI ;
Dhanda, A ;
Tian, YM ;
Masson, N ;
Hamilton, DL ;
Jaakkola, P ;
Barstead, R ;
Hodgkin, J ;
Maxwell, PH ;
Pugh, CW ;
Schofield, CJ ;
Ratcliffe, PJ .
CELL, 2001, 107 (01) :43-54
[34]   Metformin and reduced risk of cancer in diabetic patients [J].
Evans, JMM ;
Donnelly, LA ;
Emslie-Smith, AM ;
Alessi, DR ;
Morris, AD .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503) :1304-1305
[35]   Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition [J].
Fan, Yongjun ;
Dickman, Kathleen G. ;
Zong, Wei-Xing .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (10) :7324-7333
[36]   The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo [J].
Fu, LN ;
Pelicano, H ;
Liu, JS ;
Huang, P ;
Lee, CC .
CELL, 2002, 111 (01) :41-50
[37]   c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism [J].
Gao, Ping ;
Tchernyshyov, Irina ;
Chang, Tsung-Cheng ;
Lee, Yun-Sil ;
Kita, Kayoko ;
Ochi, Takafumi ;
Zeller, Karen I. ;
De Marzo, Angelo M. ;
Van Eyk, Jennifer E. ;
Mendell, Joshua T. ;
Dang, Chi V. .
NATURE, 2009, 458 (7239) :762-U100
[38]   The clock gene Per2 links the circadian system to the estrogen receptor [J].
Gery, S. ;
Virk, R. K. ;
Chumakov, K. ;
Yu, A. ;
Koeffler, H. P. .
ONCOGENE, 2007, 26 (57) :7916-7920
[39]   The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells [J].
Gery, S ;
Komatsu, N ;
Baldjyan, L ;
Yu, A ;
Koo, D ;
Koeffler, HP .
MOLECULAR CELL, 2006, 22 (03) :375-382
[40]   Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer [J].
Gery, Sigal ;
Komatsu, Naoki ;
Kawamata, Norihiko ;
Miller, Carl W. ;
Desmond, Julian ;
Virk, Renu K. ;
Marchevsky, Alberto ;
Mckenna, Robert ;
Taguchi, Hirokuni ;
Koeffler, H. Phillip .
CLINICAL CANCER RESEARCH, 2007, 13 (05) :1399-1404